REPORT ID 4783

United States Penicillin Market Report 2017

Publish Date
19-Dec-17
Pages
95
Format
Electronic (PDF)

In this report, the United States Penicillin market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
    The West
    Southwest
    The Middle Atlantic
    New England
    The South
    The Midwest
with sales (volume), revenue (value), market share and growth rate of Penicillin in these regions, from 2012 to 2022 (forecast).

United States Penicillin market competition by top manufacturers/players, with Penicillin sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    GSK
    Pfizer
    Johnson & Johnson
    Bayer HealthCare
    Abbot Laboratories
    Roche Pharmaceuticals
    Sanofi Aventis
    Takeda Pharmaceutical Company
    Toyama Chemical
    Merck & Co.

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Aminopenicillins
    Antipseudomonal Penicillins
    Beta-lactamase Inhibitors
    Natural Penicillins
    Penicillinase Resistant Penicillins
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Hospitals
    Clinics
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

United States Penicillin Market Report 2017
1 Penicillin Overview
    1.1 Product Overview and Scope of Penicillin
    1.2 Classification of Penicillin by Product Category
        1.2.1 United States Penicillin Market Size (Sales Volume) Comparison by Type (2012-2022)
        1.2.2 United States Penicillin Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
        1.2.3 Aminopenicillins
        1.2.4 Antipseudomonal Penicillins
        1.2.5 Beta-lactamase Inhibitors
        1.2.6 Natural Penicillins
        1.2.7 Penicillinase Resistant Penicillins
    1.3 United States Penicillin Market by Application/End Users
        1.3.1 United States Penicillin Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
        1.3.2 Hospitals
        1.3.3 Clinics
        1.3.4 Others
    1.4 United States Penicillin Market by Region
        1.4.1 United States Penicillin Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 The West Penicillin Status and Prospect (2012-2022)
        1.4.3 Southwest Penicillin Status and Prospect (2012-2022)
        1.4.4 The Middle Atlantic Penicillin Status and Prospect (2012-2022)
        1.4.5 New England Penicillin Status and Prospect (2012-2022)
        1.4.6 The South Penicillin Status and Prospect (2012-2022)
        1.4.7 The Midwest Penicillin Status and Prospect (2012-2022)
    1.5 United States Market Size (Value and Volume) of Penicillin (2012-2022)
        1.5.1 United States Penicillin Sales and Growth Rate (2012-2022)
        1.5.2 United States Penicillin Revenue and Growth Rate (2012-2022)

2 United States Penicillin Market Competition by Players/Suppliers
    2.1 United States Penicillin Sales and Market Share of Key Players/Suppliers (2012-2017)
    2.2 United States Penicillin Revenue and Share by Players/Suppliers (2012-2017)
    2.3 United States Penicillin Average Price by Players/Suppliers (2012-2017)
    2.4 United States Penicillin Market Competitive Situation and Trends
        2.4.1 United States Penicillin Market Concentration Rate
        2.4.2 United States Penicillin Market Share of Top 3 and Top 5 Players/Suppliers
        2.4.3 Mergers & Acquisitions, Expansion in United States Market
    2.5 United States Players/Suppliers Penicillin Manufacturing Base Distribution, Sales Area, Product Type

3 United States Penicillin Sales (Volume) and Revenue (Value) by Region (2012-2017)
    3.1 United States Penicillin Sales and Market Share by Region (2012-2017)
    3.2 United States Penicillin Revenue and Market Share by Region (2012-2017)
    3.3 United States Penicillin Price by Region (2012-2017)

4 United States Penicillin Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
    4.1 United States Penicillin Sales and Market Share by Type (Product Category) (2012-2017)
    4.2 United States Penicillin Revenue and Market Share by Type (2012-2017)
    4.3 United States Penicillin Price by Type (2012-2017)
    4.4 United States Penicillin Sales Growth Rate by Type (2012-2017)

5 United States Penicillin Sales (Volume) by Application (2012-2017)
    5.1 United States Penicillin Sales and Market Share by Application (2012-2017)
    5.2 United States Penicillin Sales Growth Rate by Application (2012-2017)
    5.3 Market Drivers and Opportunities

6  United States Penicillin Players/Suppliers Profiles and Sales Data
    6.1 GSK
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Penicillin Product Category, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 GSK Penicillin Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Pfizer
        6.2.2 Penicillin Product Category, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Pfizer Penicillin Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Johnson & Johnson
        6.3.2 Penicillin Product Category, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Johnson & Johnson Penicillin Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Bayer HealthCare
        6.4.2 Penicillin Product Category, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Bayer HealthCare Penicillin Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Abbot Laboratories
        6.5.2 Penicillin Product Category, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Abbot Laboratories Penicillin Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Roche Pharmaceuticals
        6.6.2 Penicillin Product Category, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Roche Pharmaceuticals Penicillin Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Sanofi Aventis
        6.7.2 Penicillin Product Category, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Sanofi Aventis Penicillin Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 Takeda Pharmaceutical Company
        6.8.2 Penicillin Product Category, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Takeda Pharmaceutical Company Penicillin Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 Toyama Chemical
        6.9.2 Penicillin Product Category, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 Toyama Chemical Penicillin Sales, Revenue, Price and Gross Margin (2012-2017)
        6.9.4 Main Business/Business Overview
    6.10 Merck & Co.
        6.10.2 Penicillin Product Category, Application and Specification
            6.10.2.1 Product A
            6.10.2.2 Product B
        6.10.3 Merck & Co. Penicillin Sales, Revenue, Price and Gross Margin (2012-2017)
        6.10.4 Main Business/Business Overview

7 Penicillin Manufacturing Cost Analysis
    7.1 Penicillin Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Penicillin

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Penicillin Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Penicillin Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 United States Penicillin Market Size (Value and Volume) Forecast (2017-2022)
    11.1 United States Penicillin Sales Volume, Revenue Forecast (2017-2022)
    11.2 United States Penicillin Sales Volume Forecast by Type (2017-2022)
    11.3 United States Penicillin Sales Volume Forecast by Application (2017-2022)
    11.4 United States Penicillin Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer